Active Pharmaceutical Ingredients (API) Market in Asia

July 6, 2011 - PRLog -- Asia-Pacific is the third largest regional market for APIs by revenue in the world after North America and Europe. The region is the fastest growing API market in the world. The Asia-Pacific API market grew consistently at a Compound Annual Growth Rate (CAGR) of 6.7% from 2005 to 2010. The year-on-year growth rate also increased continuously in this period. It is expected to witness an even higher growth rate in the forecast period. The Asia-Pacific API market’s revenues will grow at a CAGR of 9.6% from 2010 to 2016.

The generic sector is the dominating one in Asia-Pacific region. The generic APIs held a share of 71.5% in the region’s API revenue in 2010, while innovator APIs held a share of 28.5%. The share of innovator sector APIs is higher in Japan and lower in China and India.

Japan is the largest market for APIs in the Asia-Pacific region. Japan contributed 42.8% of the region’s total API market revenues. China is the second largest and the fastest growing API market in Asia-Pacific. China currently holds a share of 20.8% in the region’s total API market revenues. India is the third largest API market in the region accounting for a share of 10.3%. South Korea is another important API market in Asia-Pacific, accounting for a share of 8.1% in the region’s total API market revenues.


For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Act...


GBI Research’s report, “Active Pharmaceutical Ingredients (API) Market in Asia-Pacific – The Merchant Market for Generics Continues to Grow as the Competition Increases” provides detailed insight into the Asia-Pacific API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints, and competitive landscape of major producers in the region. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and SWOT analysis of the API markets in the major countries of the region. Overall, the report presents a comprehensive analysis of the Asia-Pacific API market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts


For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Active-Pharmace...


Visit our report store: http://www.gbiresearch.com

For more details contact:
pressreleases@gbiresearch.com
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782

# # #

GBI Research is a market-leading provider of business intelligence reports. GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders’ insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs